Quick Overview
This was a week of diverging regulatory paths across Europe and Asia. Spain moved to treat vaping identically to smoking in public spaces, while Italy’s Meloni government continued resisting that approach. France proposed a generational tobacco ban modeled on the UK. PMI confirmed its smoke-free pivot is accelerating with 42% of revenue now from non-combustible products. Regulators are struggling to find a coherent framework for nicotine products that fall between cigarettes and medicine.
1. Spain Approves Sweeping Tobacco Control Law — Vaping Treated Same as Smoking
Spain’s Council of Ministers approved a draft tobacco control law on July 22 that extends smoking bans to hospitality terraces, beaches, public pools, sports facilities, and national parks. The bill treats e-cigarettes (including nicotine-free devices), heated tobacco, nicotine pouches, and hookahs under the same restrictions as combustible cigarettes. A 15-meter protection zone around schools, hospitals, and playgrounds was also created.
This is a significant escalation from Spain’s 2005 tobacco law. The hospitality sector opposes the terrace ban, warning it will push consumption into private homes. The legislation now moves to parliament, where amendments could narrow or expand its scope. Spain joins a growing list of jurisdictions equating vaping with smoking in public spaces, a policy approach that ignores the established risk difference between combustion and non-combustion.
2. PMI Q2 2026: Smoke-Free Revenue Breaks $11 Billion
Philip Morris International reported Q2 results on July 22 with net revenues of $11.2 billion, up 10.4% year-over-year. Smoke-free products now represent approximately 42% of total sales. IQOS heat-not-burn shipments rose 7.6%, and VEEV e-vapor shipments jumped 55.1%. Zyn nicotine pouches are now available in 60 markets, with shipments rising 1.8% to 2.9 billion pouches in the U.S. alone.
Adjusted diluted EPS rose 15.2% to $2.20, though reported EPS fell 7.7% to $1.80 due to a $511 million non-cash impairment charge. PMI maintained its 2026 outlook. What’s clear: PMI’s smoke-free transition is past the point of no return. The company now generates more revenue from non-combustible products than from cigarettes in many markets. IQOS remains the dominant heat-not-burn platform globally, and Zyn’s expansion into 60 markets signals that the nicotine pouch category is not slowing down.
3. UK Plain Packaging Rules: Vape Group Warns of £330M in Losses
Advocacy group We Vape warned that the UK government’s proposed restrictions on vape packaging, device colors, and retail display could cost the industry more than £330 million in lost profits and compliance costs. The government’s own impact assessment reportedly estimates £328 million in lost profits for approximately 76,000 retailers, plus £2.8 million in compliance costs. We Vape also criticized the planned £100,000 enforcement budget as laughably inadequate.
The proposed rules (standardized white packaging, devices limited to black/white/gray, flavor names restricted to simple descriptors, and out-of-sight retail display) are part of a 12-week consultation that runs through October 2. The consultation is open to the public and industry stakeholders. The £330 million figure, if accurate, represents a significant economic impact that the government’s cost-benefit analysis may not have fully accounted for.
4. France Proposes Generational Tobacco Ban — Sales to Anyone Born After 2009
France’s National Health Insurance (Cnam) recommended a permanent ban on tobacco sales to anyone born after 2009, modeled on the UK’s Tobacco and Vapes Act. The proposal, published in Cnam’s annual report on July 2, would mean that current 17-year-olds and younger would never be able to legally purchase tobacco products in France. Health Minister Stéphanie Rist and six former health ministers have expressed support. A cross-party bill has been introduced by Green MP Nicolas Thierry.
The proposal faces opposition from the National Confederation of Tobacconists, who argue that France’s open land borders with lower-tax countries will drive consumers to black markets rather than quitting. The debate is complicated by the rise of vaping: industry groups argue that alternative nicotine products serve as harm reduction tools, while public health advocates point to Sweden’s sub-5% smoking rate as a model achieved through comprehensive regulation, not product promotion. The issue will be debated during the autumn review of the Social Security Financing Bill.
5. Italy vs Spain: Two Visions for European Vape Policy
This week highlighted the growing divide in European nicotine regulation. While Spain moved to treat vaping identically to smoking, Italy’s Meloni government has taken a different approach. Milan’s 2025 outdoor smoking ban specifically exempts vaping, and the Meloni coalition has resisted EU recommendations to regulate heated tobacco identically to cigarettes. Deputy Prime Minister Matteo Salvini has publicly defended e-cigarettes as a viable alternative for smokers.
The contrast is instructive. Spain’s approach treats all nicotine products as equivalent, ignoring the relative risk data. Italy’s approach, while not a formal harm reduction strategy, at least preserves differentiated regulation. The European Tobacco Control Scale penalizes Italy for this, awarding it only 12 of 22 points for smoke-free environments because heated tobacco is not regulated like cigarettes. But from a harm reduction perspective, that “lower score” reflects a more evidence-based policy. The EU’s broader nicotine policy debate will determine which approach wins out.
6. Malaysia Health Advocates Renew Call for Nationwide Vape Ban
Public health groups in Malaysia renewed calls for a total ban on vaping products, citing government data showing that 73% of drug abuse cases in the country involve synthetic drugs. Consumer advocates and mental health experts argue that e-cigarettes are increasingly being used to consume ketamine, etomidate, and other synthetic drugs. This follows reports that Malaysian authorities confiscated 700kg of drug-laced vapes since 2023.
The renewed push is part of a broader Southeast Asian trend. Indonesia is also considering stricter e-cigarette restrictions. The argument conflates two separate issues (contaminated black-market products and legitimate vaping products), but it’s politically effective. The pattern mirrors arguments used in the U.S. around THC vapes: a contaminated product problem is used to justify restrictions on all vapor products. The key question is whether Malaysia’s regulators will distinguish between drug-laced products and legitimate nicotine alternatives.
7. Study: Nicotine Pouches Linked to Gum Recession
A Swedish study from the Karolinska Institute found that 45% of nicotine pouch users exhibited receding gums, compared with 52% of snus users and just 6% of non-users. The damage typically occurred at the placement site. Pouch users also experienced more gum irritation than snus users, which researchers linked to flavoring ingredients.
The study adds important data to the emerging pouch safety profile. While the absence of tobacco eliminates exposure to many carcinogens, oral health effects are real and non-trivial. The finding that flavoring ingredients may contribute to irritation is particularly relevant as regulators debate flavor restrictions. What this means isn’t that pouches are “dangerous” (they remain far safer than smoking) but that they are not risk-free. Understanding the difference between eliminating tobacco and eliminating all risk matters for informed consumer choice.
Weekly Trends & Analysis
The dominant theme this week is the fragmentation of regulatory approaches. Within Europe alone, we now have three distinct models emerging: Spain’s “treat everything the same” approach, Italy’s “differentiate by risk” approach, and the UK’s “ban disposables, restrict packaging” middle ground. This fragmentation is not just academic. It creates real problems for manufacturers, retailers, and consumers operating across borders.
Meanwhile, the industry is moving faster than the regulators. PMI’s Q2 numbers show that smoke-free products are approaching half of total revenue. The company’s investment in Zyn (now in 60 markets) signals that nicotine pouches are the next battleground. The Karolinska study on gum health is an early warning that pouches will face their own health scrutiny, and the industry should be prepared for that.
The Malaysia story is a reminder that the drug-laced vape narrative is gaining traction in Southeast Asia, with potential for spillover effects on legitimate products. This is a pattern we’ve seen before: a real problem (contaminated products) becomes the basis for broad restrictions that affect all vapor products.
What to Watch Next Week
- Spain’s parliamentary process: The draft law moves to parliament, where amendments could narrow or expand its scope. The hospitality industry’s opposition suggests the terrace ban may face significant debate.
- UK consultation response: Industry groups are mobilizing to submit responses to the 12-week consultation before the October 2 deadline. The We Vape £330 million estimate will likely be a central argument.
- France’s PLFSS debate: The generational tobacco ban proposal will be debated during the autumn Social Security Financing Bill review. The strength of political support will become clearer.
- PMI earnings fallout: The $511 million impairment charge and currency headwinds bear watching. PMI’s stock rose 5% despite the charge, suggesting investors are focused on smoke-free growth.
- EU nicotine tax debate: The Irish presidency of the EU Council will continue negotiating the Tobacco Excise Directive. The divide between pro-taxation and anti-taxation member states remains unresolved.
Kevin Li — Founder & Editor, VapeObservation.com Kevin reviews vape products hands-on, prioritizing real-world performance over manufacturer claims. His goal: honest, practical advice that helps everyday vapers make informed choices. Before launching VapeObservation, he was a longtime vaper frustrated by promotional content disguised as reviews. Every article on the site reflects his commitment to data-driven, reader-first testing.
